Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Expression vector-derived heterogeneity in a therapeutic IgG4 monoclonal antibody.

Rehder DS, Wisniewski CJ, Liu D, Ren D, Farnan D, Schenauer MR.

MAbs. 2019 Jan;11(1):145-152. doi: 10.1080/19420862.2018.1540254. Epub 2018 Nov 7.

PMID:
30365358
2.

Stage Dependence, Cell-Origin Independence, and Prognostic Capacity of Serum Glycan Fucosylation, β1-4 Branching, β1-6 Branching, and α2-6 Sialylation in Cancer.

Ferdosi S, Rehder DS, Maranian P, Castle EP, Ho TH, Pass HI, Cramer DW, Anderson KS, Fu L, Cole DEC, Le T, Wu X, Borges CR.

J Proteome Res. 2018 Jan 5;17(1):543-558. doi: 10.1021/acs.jproteome.7b00672. Epub 2017 Nov 21.

3.

Glycan structure of Gc Protein-derived Macrophage Activating Factor as revealed by mass spectrometry.

Borges CR, Rehder DS.

Arch Biochem Biophys. 2016 Sep 15;606:167-79. doi: 10.1016/j.abb.2016.08.006. Epub 2016 Aug 5.

PMID:
27503803
4.

Characterization of additional vitamin D binding protein variants.

Fu L, Borges CR, Rehder DS, Wong BY, Williams R, Carpenter TO, Cole DE.

J Steroid Biochem Mol Biol. 2016 May;159:54-9. doi: 10.1016/j.jsbmb.2016.02.022. Epub 2016 Feb 23.

PMID:
26924582
5.

Gamma-carboxylation and fragmentation of osteocalcin in human serum defined by mass spectrometry.

Rehder DS, Gundberg CM, Booth SL, Borges CR.

Mol Cell Proteomics. 2015 Jun;14(6):1546-55. doi: 10.1074/mcp.M114.047621. Epub 2015 Apr 8.

6.

Mass Spectrometric Immunoassay for the qualitative and quantitative analysis of the cytokine Macrophage Migration Inhibitory Factor (MIF).

Sherma ND, Borges CR, Trenchevska O, Jarvis JW, Rehder DS, Oran PE, Nelson RW, Nedelkov D.

Proteome Sci. 2014 Oct 14;12(1):52. doi: 10.1186/s12953-014-0052-3. eCollection 2014.

7.

Elevated plasma albumin and apolipoprotein A-I oxidation under suboptimal specimen storage conditions.

Borges CR, Rehder DS, Jensen S, Schaab MR, Sherma ND, Yassine H, Nikolova B, Breburda C.

Mol Cell Proteomics. 2014 Jul;13(7):1890-9. doi: 10.1074/mcp.M114.038455. Epub 2014 Apr 15.

8.

Parallel workflow for high-throughput (>1,000 samples/day) quantitative analysis of human insulin-like growth factor 1 using mass spectrometric immunoassay.

Oran PE, Trenchevska O, Nedelkov D, Borges CR, Schaab MR, Rehder DS, Jarvis JW, Sherma ND, Shen L, Krastins B, Schwenke DC, Reaven PD, Nelson RW.

PLoS One. 2014 Mar 24;9(3):e92801. doi: 10.1371/journal.pone.0092801. eCollection 2014. Erratum in: PLoS One. 2014;9(5):e95812. Lopez, Mary F [removed].

9.

Multiplexed surrogate analysis of glycotransferase activity in whole biospecimens.

Borges CR, Rehder DS, Boffetta P.

Anal Chem. 2013 Mar 5;85(5):2927-36. doi: 10.1021/ac3035579. Epub 2013 Feb 15.

10.

Building multidimensional biomarker views of type 2 diabetes on the basis of protein microheterogeneity.

Borges CR, Oran PE, Buddi S, Jarvis JW, Schaab MR, Rehder DS, Rogers SP, Taylor T, Nelson RW.

Clin Chem. 2011 May;57(5):719-28. doi: 10.1373/clinchem.2010.156976. Epub 2011 Mar 14.

11.

Cysteine sulfenic acid as an intermediate in disulfide bond formation and nonenzymatic protein folding.

Rehder DS, Borges CR.

Biochemistry. 2010 Sep 7;49(35):7748-55. doi: 10.1021/bi1008694.

12.
13.

Full-length characterization of proteins in human populations.

Borges CR, Rehder DS, Jarvis JW, Schaab MR, Oran PE, Nelson RW.

Clin Chem. 2010 Feb;56(2):202-11. doi: 10.1373/clinchem.2009.134858. Epub 2009 Nov 19. Review.

14.

Glycosylation status of vitamin D binding protein in cancer patients.

Rehder DS, Nelson RW, Borges CR.

Protein Sci. 2009 Oct;18(10):2036-42. doi: 10.1002/pro.214.

15.

Structural and functional characterization of disulfide isoforms of the human IgG2 subclass.

Dillon TM, Ricci MS, Vezina C, Flynn GC, Liu YD, Rehder DS, Plant M, Henkle B, Li Y, Deechongkit S, Varnum B, Wypych J, Balland A, Bondarenko PV.

J Biol Chem. 2008 Jun 6;283(23):16206-15. doi: 10.1074/jbc.M709988200. Epub 2008 Mar 12.

16.

Automated tryptic digestion procedure for HPLC/MS/MS peptide mapping of immunoglobulin gamma antibodies in pharmaceutics.

Chelius D, Xiao G, Nichols AC, Vizel A, He B, Dillon TM, Rehder DS, Pipes GD, Kraft E, Oroska A, Treuheit MJ, Bondarenko PV.

J Pharm Biomed Anal. 2008 Jun 9;47(2):285-94. doi: 10.1016/j.jpba.2008.01.018. Epub 2008 Jan 19.

PMID:
18313251
17.

Isomerization of a single aspartyl residue of anti-epidermal growth factor receptor immunoglobulin gamma2 antibody highlights the role avidity plays in antibody activity.

Rehder DS, Chelius D, McAuley A, Dillon TM, Xiao G, Crouse-Zeineddini J, Vardanyan L, Perico N, Mukku V, Brems DN, Matsumura M, Bondarenko PV.

Biochemistry. 2008 Feb 26;47(8):2518-30. doi: 10.1021/bi7018223. Epub 2008 Jan 31.

PMID:
18232715
18.

Formation of pyroglutamic acid from N-terminal glutamic acid in immunoglobulin gamma antibodies.

Chelius D, Jing K, Lueras A, Rehder DS, Dillon TM, Vizel A, Rajan RS, Li T, Treuheit MJ, Bondarenko PV.

Anal Chem. 2006 Apr 1;78(7):2370-6.

PMID:
16579622
19.

Optimization of a reversed-phase high-performance liquid chromatography/mass spectrometry method for characterizing recombinant antibody heterogeneity and stability.

Dillon TM, Bondarenko PV, Rehder DS, Pipes GD, Kleemann GR, Ricci MS.

J Chromatogr A. 2006 Jul 7;1120(1-2):112-20. Epub 2006 Jan 30.

PMID:
16448656
20.

Reversed-phase liquid chromatography/mass spectrometry analysis of reduced monoclonal antibodies in pharmaceutics.

Rehder DS, Dillon TM, Pipes GD, Bondarenko PV.

J Chromatogr A. 2006 Jan 13;1102(1-2):164-75. Epub 2005 Nov 17.

PMID:
16297926
21.

Supplemental Content

Loading ...
Support Center